James Patrick Kelly - Net Worth and Insider Trading
James Patrick Kelly Net Worth
The estimated net worth of James Patrick Kelly is at least $969,850 dollars as of 2024-11-10. James Patrick Kelly is the EVP & CFO of Vanda Pharmaceuticals Inc and owns about 186,869 shares of Vanda Pharmaceuticals Inc (VNDA) stock worth over $969,850. Details can be seen in James Patrick Kelly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Patrick Kelly has not made any transactions after 2020-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Patrick Kelly
James Patrick Kelly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Patrick Kelly owns 3 companies in total, including Supernus Pharmaceuticals Inc (SUPN) , Vanda Pharmaceuticals Inc (VNDA) , and Novavax Inc (NVAX) .
Click here to see the complete history of James Patrick Kelly’s form 4 insider trades.
Insider Ownership Summary of James Patrick Kelly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SUPN | Supernus Pharmaceuticals Inc | 2020-10-12 | Executive Vice-President & CFO |
| VNDA | Vanda Pharmaceuticals Inc | 2020-03-03 | SVP & CFO & Treasurer & Secretar |
| NVAX | Novavax Inc | 2021-08-16 | EVP & CFO and Treasurer |
James Patrick Kelly Latest Holdings Summary
James Patrick Kelly currently owns a total of 1 stock. James Patrick Kelly owns 186,869 shares of Vanda Pharmaceuticals Inc (VNDA) as of March 3, 2020, with a value of $969,850.
Latest Holdings of James Patrick Kelly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc | 2020-03-03 | 186,869 | 5.19 | 969,850 |
Holding Weightings of James Patrick Kelly
James Patrick Kelly Form 4 Trading Tracker
According to the SEC Form 4 filings, James Patrick Kelly has made a total of 2 transactions in Vanda Pharmaceuticals Inc (VNDA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Vanda Pharmaceuticals Inc is the sale of 18,857 shares on March 3, 2020, which brought James Patrick Kelly around $195,359.
Insider Trading History of James Patrick Kelly
- 1
James Patrick Kelly Trading Performance
GuruFocus tracks the stock performance after each of James Patrick Kelly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Patrick Kelly is -19.87%. GuruFocus also compares James Patrick Kelly's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Patrick Kelly within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Patrick Kelly's insider trading performs compared to the benchmark.
Performance of James Patrick Kelly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.53 | | | | | |
| Relative Return to S&P 500(%) | -11.42 | | | | | |
James Patrick Kelly Ownership Network
Ownership Network List of James Patrick Kelly
Ownership Network Relation of James Patrick Kelly
James Patrick Kelly Owned Company Details
What does Supernus Pharmaceuticals Inc do?
Who are the key executives at Supernus Pharmaceuticals Inc?
James Patrick Kelly is the Executive Vice-President & CFO of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include director & President & CEO Jack A. Khattar , Sr VP & Quality & GMP Oper. & IT Frank Mottola , and Sr. VP of IP & CSO Padmanabh P. Bhatt .
Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary
Over the past 18 months, James Patrick Kelly made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 98,505 shares made by Padmanabh P. Bhatt , a net sale of 21,235 shares made by Tami Tillotson Martin , and a net sale of 28,099 shares made by Georges Gemayel .
In summary, during the past 3 months, insiders sold 168,099 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 168,099 shares. During the past 18 months, 300,542 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 300,542 shares.
Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Supernus Pharmaceuticals Inc Insider Transactions
James Patrick Kelly Mailing Address
Above is the net worth, insider trading, and ownership report for James Patrick Kelly. You might contact James Patrick Kelly via mailing address: C/o Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
